Finzati - Logo
MYNZ logo

Mainz Biomed B.V.

MYNZ • Medical - Diagnostics & Research
$3.59
▲ +0.03 (+0.84%)
Current price
EarningsLatest report: Dec 31, 2025
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$14.69M
Growth
24.5%
Cash Flow
0/5
Trend
Negative
Evidence
High debt level · 4.01Weak liquidity · 0.5Weak profitability
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Dec 31, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$3.59
Change0.84%
Market Cap$14.69M
52W Range0.55 - 5.34
Beta0.32
Gross Margin-42.07%
Oper. Margin-25.13%
Profit Margin-30.18%
Debt/Eq4.01
Current Ratio0.50
Quick Ratio0.44
Revenue 5Y24.52%

Investment DNA

How strong this company looks for long-term investors

29
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
39/100
Growth Potential
Revenue and expansion
48/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
High debt level · 4.01Weak liquidity · 0.5Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 11/5/2021
Industry: Medical - Diagnostics & Research
P/B i: 10.47
Debt / Equity i: 4.01
Operating Margin: -2513.37%
Net Margin: -3018.31%
ROE i: -
ROIC: -

Financial Health

Score8 / 20
Debt / Equity: 4.01
Current Ratio: 0.50
Quick Ratio: 0.44
Status: Moderate

Warnings

  • High debt level
  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

Ben-Tzvi Avraham
Transaction: 05/08/2026
BUY
Change
+137,141
Price
Not reported
Filing
05/26/2026
Type
BUY
NATAN DAVID
Transaction: 05/08/2026
BUY
Change
+137,141
Price
Not reported
Filing
05/21/2026
Type
BUY
Lazar David E.
Transaction: 04/22/2026
BUY
Change
+1,000,000
Price
Not reported
Filing
04/28/2026
Type
BUY